These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 16997640)

  • 1. Simultaneous determination of 8 HIV protease inhibitors in human plasma by isocratic high-performance liquid chromatography with combined use of UV and fluorescence detection: amprenavir, indinavir, atazanavir, ritonavir, lopinavir, saquinavir, nelfinavir and M8-nelfinavir metabolite.
    Verbesselt R; Van Wijngaerden E; de Hoon J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jan; 845(1):51-60. PubMed ID: 16997640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of the new HIV protease inhibitor lopinavir (ABT 378) and of indinavir(1), amprenavir, saquinavir, ritonavir (ABT 538)(2) and nelfinavir(3) in human plasma by gradient HPLC.
    Kuschak D; Mauss S; Schmutz G; Gantke B
    Clin Lab; 2001; 47(9-10):471-7. PubMed ID: 11596909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple and simultaneous determination of the hiv-protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir plus M8 nelfinavir metabolite and the nonnucleoside reverse transcriptase inhibitors efavirenz and nevirapine in human plasma by reversed-phase liquid chromatography.
    Poirier JM; Robidou P; Jaillon P
    Ther Drug Monit; 2005 Apr; 27(2):186-92. PubMed ID: 15795650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of atazanavir and other antiretroviral drugs (indinavir, amprenavir, nelfinavir and its active metabolite M8, saquinavir, ritonavir, lopinavir, nevirapine and efavirenz) plasma levels by high performance liquid chromatography with UV detection.
    Dailly E; Raffi F; Jolliet P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Dec; 813(1-2):353-8. PubMed ID: 15556553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An isocratic liquid chromatography method for determining HIV non-nucleoside reverse transcriptase inhibitor and protease inhibitor concentrations in human plasma.
    Weller DR; Brundage RC; Balfour HH; Vezina HE
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):369-73. PubMed ID: 17081812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of HIV protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
    Dickinson L; Robinson L; Tjia J; Khoo S; Back D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 829(1-2):82-90. PubMed ID: 16226495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of the six HIV protease inhibitors (amprenavir, indinavir, lopinavir, nelfinavir, ritonavir, and saquinavir) plus M8 nelfinavir metabolite and the nonnucleoside reverse transcription inhibitor efavirenz in human plasma by solid-phase extraction and column liquid chromatography.
    Poirier JM; Robidou P; Jaillon P
    Ther Drug Monit; 2002 Apr; 24(2):302-9. PubMed ID: 11897976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-performance liquid chromatography assay for the determination of the HIV-protease inhibitor tipranavir in human plasma in combination with nine other antiretroviral medications.
    Choi SO; Rezk NL; Kashuba AD
    J Pharm Biomed Anal; 2007 Mar; 43(4):1562-7. PubMed ID: 17236737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of 8 HIV-protease inhibitors and 2 nonnucleoside reverse transcriptase inhibitors by ultra-performance liquid chromatography with diode array detection.
    Elens L; Veriter S; Di Fazio V; Vanbinst R; Boesmans D; Wallemacq P; Haufroid V
    Clin Chem; 2009 Jan; 55(1):170-4. PubMed ID: 19028822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the new HIV-protease inhibitor atazanavir by liquid chromatography after solid-phase extraction.
    Colombo S; Guignard N; Marzolini C; Telenti A; Biollaz J; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(1):25-34. PubMed ID: 15358304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extraction.
    Marzolini C; Telenti A; Buclin T; Biollaz J; Decosterd LA
    J Chromatogr B Biomed Sci Appl; 2000 Mar; 740(1):43-58. PubMed ID: 10798293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry.
    Colombo S; Beguin A; Telenti A; Biollaz J; Buclin T; Rochat B; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(2):259-76. PubMed ID: 15833290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatographic assay to determine the plasma levels of HIV-protease inhibitors (amprenavir, indinavir, nelfinavir, ritonavir and saquinavir) and the non-nucleoside reverse transcriptase inhibitor (nevirapine) after liquid-liquid extraction.
    Dailly E; Thomas L; Kergueris MF; Jolliet P; Bourin M
    J Chromatogr B Biomed Sci Appl; 2001 Jul; 758(2):129-35. PubMed ID: 11486821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of the HIV-protease inhibitors indinavir, amprenavir, ritonavir, saquinavir and nelfinavir in human plasma by reversed-phase high-performance liquid chromatography.
    Sarasa-Nacenta M; López-Púa Y; Mallolas J; Blanco JL; Gatell JM; Carné X
    J Chromatogr B Biomed Sci Appl; 2001 Jun; 757(2):325-32. PubMed ID: 11417878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic monitoring of HIV-1 protease inhibitors in the antiretroviral therapy.
    Pawiński T; Pulik P; Gralak B; Horban A
    Acta Pol Pharm; 2008; 65(1):93-100. PubMed ID: 18536180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of the HIV drugs indinavir, amprenavir, saquinavir, ritonavir, lopinavir, nelfinavir, the nelfinavir hydroxymetabolite M8, and nevirapine in human plasma by reversed-phase high-performance liquid chromatography.
    Droste JA; Verweij-Van Wissen CP; Burger DM
    Ther Drug Monit; 2003 Jun; 25(3):393-9. PubMed ID: 12766571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
    Crommentuyn KM; Rosing H; Nan-Offeringa LG; Hillebrand MJ; Huitema AD; Beijnen JH
    J Mass Spectrom; 2003 Feb; 38(2):157-66. PubMed ID: 12577282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir and nelfinavir in human plasma by high-performance liquid chromatography.
    Yamada H; Kotaki H; Nakamura T; Iwamoto A
    J Chromatogr B Biomed Sci Appl; 2001 May; 755(1-2):85-9. PubMed ID: 11393736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse phase high-performance liquid chromatography method for the analysis of amprenavir, efavirenz, indinavir, lopinavir, nelfinavir and its active metabolite (M8), ritonavir, and saquinavir in heparinized human plasma.
    Keil K; Frerichs VA; DiFrancesco R; Morse G
    Ther Drug Monit; 2003 Jun; 25(3):340-6. PubMed ID: 12766563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.
    Titier K; Lagrange F; Péhourcq F; Edno-Mcheik L; Moore N; Molimard M
    Ther Drug Monit; 2002 Jun; 24(3):417-24. PubMed ID: 12021635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.